desk
Share
News Topical, Digital Desk : Goa-based point-of-care diagnostics company Molbio Diagnostics has filed a draft red herring prospectus (DRHP) for an IPO with SEBI. The company plans to raise Rs 200 crore through a fresh issue and sell the remaining shares through an offer-for-sale (OFS). According to the draft papers, the company will raise Rs 200 crore through a new issue, while the rest of the funds will be through OFS (offer-for-sale). The company's existing shareholders, including promoters and investors, will sell 1.25 crore equity shares through OFS.
Promoters Exxora Trading LLP and Chandrasekhar Bhaskaran Nair, who hold 46.65 per cent stake, will sell 29.12 lakh shares through OFS. Investors such as V Sciences Investments, India Business Excellence Fund III, Gopalkrishna M Kini, Gopalakrishna Sampathgiri, J Guru Dutt, Sangeetha M Kini and MA Usha Rani, who hold 53.35 per cent stake, will sell 96.44 lakh shares through OFS.
Who are the big shareholders Among the investors, India Business Excellence Fund III and V-Sciences Investments are the largest shareholders after promoter Exxora Trading. Their stake is 12.66 per cent and 8.93 per cent. These investors have been invested in the company since January 2021 and September 2022.
About the Company The Company was founded in 2000 and the last share transaction took place on July 14, 2025, in which Shruthi G Kini transferred 9,175 shares to Navin Mahavirprasad Dalmia at Rs 5,450 per share. Recently, a 4:1 bonus issue was announced on July 29, 2025, which led to an adjusted issue price of the shares at Rs 1,090 per share. Accordingly, the valuation of Molbio Diagnostics is Rs 12,490.8 crore.
--Advertisement--
